Table 3 Factors associated with inappropriate and excessive use of SABA

Socio-demographic

Sex (female = 1)

0.67

0.65–0.68

<.0001

0.50

0.47–0.54

<.0001

Higher SES

0.97

0.96–0.97

<.0001

0.92

0.91–0.94

<.0001

Year

0.98

0.98–0.98

<.0001

0.99

0.98–0.99

<.0001

Age (per 10 years increase)

1.05

1.05–1.06

<.0001

1.36

1.33–1.39

<.0001

Type & quality of care for asthma

Having received pulmonary function test

0.86

0.82–0.89

<.0001

0.90

0.83–0.98

0.0006

Respirologist consultation

0.70

0.66–0.75

<.0001

1.18

1.07–1.31

<.0001

Internal medicine consultation

0.69

0.65–0.74

<.0001

1.06

0.95–1.18

0.317

Allergist consultation

0.48

0.45–0.51

<.0001

0.34

0.28–0.41

<.0001

General Practitioner visits

No visit

–

–

–

–

–

–

1 visit PY

1.24

1.22–1.26

<.0001

1.58

1.51–1.66

<.0001

2 visits PY

1.29

1.27–1.32

<.0001

2.46

2.33–2.61

<.0001

More than 2 visits

1.73

1.69–1.77

<.0001

7.24

6.8–7.71

<.0001

Continuity of care (COC)

COC = 0

–

–

–

–

–

–

COC > 0 and COC < 50%

0.73

0.71–0.75

<.0001

0.92

0.85–0.99

0.0275

COC > =50% and COC < 100%

0.77

0.75–0.8

<.0001

0.94

0.85–1.03

0.1953

COC = 100%

0.82

0.79–0.85

<.0001

0.96

0.84–1.08

0.4703

Asthma-related hospitalisation

1.46

1.34–1.58

<.0001

1.48

1.33–1.65

<.0001

Appropriate use of ICS

0.10

0.10–0.11

<.0001

0.09

0.09–0.10

<.0001

Systemic corticosteroid

0.61

0.60–0.63

<.0001

1.80

1.72–1.90

<.0001

Comorbidity-related variables

Modified Charlson score (SD)

0.99

0.97–1.00

0.1371

0.95

0.91–1.00

0.0201

None asthma related outpatient resource utilisations

< 5 times

–

–

–

–

–

–

<=5 and > 10 times

0.77

0.76–0.79

<.0001

0.84

0.79–0.89

<.0001

<=10 and > 20 times

0.68

0.67–0.7

<.0001

0.79

0.74–0.85

<.0001

> 20 times

0.63

0.61–0.65

<.0001

0.81

0.75–0.88

<.0001

None asthma related hospitalisation

1.09

1.07–1.11

<.0001

1.33

1.27–1.39

<.0001